Home / Drug shortages / Ketorolac Tromethamine Tablet

Ketorolac Tromethamine Tablet — FDA Drug Shortage

To Be Discontinued — Mylan Pharmaceuticals Inc., a Viatris Company

The FDA lists a drug shortage record for Ketorolac Tromethamine Tablet (tablet) from Mylan Pharmaceuticals Inc., a Viatris Company with status To Be Discontinued. The shortage was first posted on 04/20/2026.

Shortage Details

Status
To Be Discontinued
Company
Mylan Pharmaceuticals Inc., a Viatris Company
Package NDC
0378-1134-01
Dosage Form
Tablet
Presentation
Ketorolac Tromethamine, Tablet, 10 mg (NDC 0378-1134-01)
Initial Posting
04/20/2026
Revised Date

FDA data resources